The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
76 - Can you please clarify if there are any differences in terms of the PAAB review of an NOC/c product vs a product with full NOC?
-
Health Canada has advised the PAAB to be cautious about approving advertising for products approved as Notice of Compliance with Conditions (NOC/C). There are some special conditions. Health Canada has approved the guideline that the PAAB has posted on the PAAB web-site https://www.paab.ca/Guidance_on_Advertising_for_Drugs_with_Notice_of_Compliance_with_Conditions_(NOCc)Feb_2018(typofix)_docx.pdf You can access that web page for full details.
